IN FORCE SEZ / EOU / FTWZ

Agenda of Approval Committee meeting to be held on 09.06.2026 -JNPA SEZ.

Reliability

In force — no superseding record on file.

Document text

SEEPZ SPECIAL ECONOMIC ZONE

ANDHERI (EAST), MUMBAI

ara& fer AGENDA FOR :

==> picture [2 x 16] intentionally omitted <==

----- Start of picture text ----- , ----- End of picture text -----

ADA Wate AGS We _sraiel (INPA) & Hedt Ager ArexEat fasts anf ata (Special Economic Zone) # fer | Taster saAlga alate Ar doa] MEETING OF THE APPROVAL COMMITTEE FOR SECTOR SPECIFIC SPECIAL ECONOMIC ZONE MULTI SECTOR OF M/s. Jawaharlal Nehru Port Authority (JNPA). ; , dss! VENUE : Conference Hall, 2"¢ Floor, The Office of the Development Commissioner, SEEPZ-SEZ, Andheri (East), Mumbai. festa : TTC, 09 June 2026 DATE : Tuesday, 09 June 2026 12:00 HURTS (GITEX 12:00 Ts) TIME : 12:00 PM Merde =: 71d dow |

aaa 12:00 HURTS (GITEX 12:00 Ts) TIME : 12:00 PM

Meeting ‘71st No

ee oe oe oe 2 2 oie ie 2 OK ok ook ob ok OK oR oe oR oo OK KE KE

q j

Hat aareterea Age We aaihtet (INPA-SEZ) & aedheeeyt sq Veer-fAfase fasts aiff att (Sector Specific Special Economic Zone for Multisector) # Watr HW frara arqea, dieg-vages (SEEPZ-SEZ) #1 sreqaiat A Aaean, 09 aT 2026 a araiferer sealaet aiatfa fr doa! Meetingof the Approval Committee for Sector Specific Special Economic Zone for Multisector of M/s. Jawaharlal Nehru Port Authority JNPA-SEZ under the Chairmanship of Development Commissioner, SEEPZ-SEZ on Tuesday, 09th June 2026.

Waar /INDEX

|easypo|nnn apres|nnn apres|gay|aii<br>[-1:Ci<br>LAGOS<br>skWATE<br>Lae|i ee|
|---|---|---|---|---|---|
||Agenda Item||No.|Subject||
||mre|Ae HATH 01:-||27.04.2026 afsaferson&Hrige Ar||
||Agenda|ItemNo.01:-||gsc |<br>ra]||
|||||Confirmations of the<br>minutes<br>of the||
|!||||meeting to be held on 27.04.2026||
||arial|ae wats 02:-||aeerticl cant fanaa stertidr-wassis,||
||Agenda|Item No. 02: -||BUT, Tat Has - 400702 & BaeL-6, cae||
|||.||dea 603 wt Kee 8,500 at Hex Sawer||
|||||A ORR<br>“Hm” A afela fase silvia||
|||||ast &<br>Waest 8 A wanes||
||||||wayenen Wede fates a wea +||
|||||way Fl||
||||||||
|||||The<br>proposal<br>of<br>M/s.<br>SRS||
|||||Pharmaceuticals<br>Private<br>Limited<br>for||
|||||carrying out Manufacturing activities of||
|||||various Pharma Items and Research &||
|||||Development<br>Services,<br>as<br>detailed<br>in||
|||||Annexure “A”, overan areaadmeasuring||
|||||8,500 Sq. Mtrs. at Plot No. 603, Sector-||
|||||6, JNPT SEZ, developed by JNPT, Uran,||
|||||Navi Mumbai — 400702.||
||wre|Ae HATH 03:-||vareag-wadseryes,<br>stvatiy,||
||Agenda|ItemNo.03:-||BMT, aay aes A feta faquatet Wasals||
|||||sais<br>HF, faat fre wena watcor &,||
|||||4,370.05datweaifdteaatasist&||

aaa A Aes wasn! seals we wsde fataes A wed Haat| Application received from M/s. SRV Global Freight: Pvt. Ltd. for addition of area admeasuring 4,370.05 Sq. ft. to the already existing SEZ Unit located at NSBP-FTWZ, JNPA, Uran, Navi Mumbai without revision in projections. Seve deve de de dete ede derek doe ek ick ek kee

“4

ea admeasuring 4,370.05 Sq. ft. to the already existing SEZ Unit located at NSBP-FTWZ, JNPA, Uran, Navi Mumbai without revision in projections. Seve deve de de dete ede derek doe ek ick ek kee

“4

fear 3iege, etcsr-ast Sr sreaetar a 28.04.2026 ar fedta aa tics dar de, iow Vs, Fas «Ff Feet aeatie-ds, argqear-3er, adt yes-400707 & aa Tay ania aa & fae sqaled afafa &r 70di doa ar arage|

Minutes of 70" Meeting of the Approval Committee for Multi Sector Specific Special Economic Zone of M/s. JNPA-SEZ, Taluka-Uran, Navi Mumbai-400707 under the Chairmanship of Development Commissioner, SEEPZ-SEZ held on 28.04.2026, at Second Floor SEEPZ Service Centre, SEEPZ SEZ, Mumbai.

|Name of the SEZ<br>|<br>i.<br>pee<br>|<br>Sector<br>||Name of the SEZ<br>|<br>i.<br>pee<br>|<br>Sector<br>||M/s. Jawaharlal Nehru PortAuthority.<br>= sae WHS<br>MultiProductSEZ||||
|---|---|---|---|---|
|Aiea aa||70af|||
|Meeting No.||~<br>70th|||
|fear|||28.04.2026||||
|Date||28.04.2026|||

Sua Waes/ _Members _Members Present:

==> picture [500 x 340] intentionally omitted <==

----- Start of picture text ----- Waes/ _Members _Members Present: ae 2! Uaea aT aret Ua oT ala Waloat ’ Name of Members _ Designation Organization 1 at. FAX 3K. AAA Taw Pare 31am, aesr-aat Shri. Mayur R. Mankar. Jt.CommissionerDevelopment SEEPZ-SEZ 2 att. Geter srearet aaay wee = |e HQ Hales, Aas H arferct Shri. Sunil Aghawane — [Joint Commissioner, Income} Nominee of Commissioner of Income Tax Tax office, Mumbai 3 a aradg quay 3g fades srettemdl aifattr sattendl,aad & area Shri. Backiyavelu Mutharasu| Deputy Director DGFT Nominee of the Additional DGFT, Mumbai 4 aft dig tel weanHar yew sry | Mar Yoo pw, SAN, Vat arf, Shri Ravindra Keny Assistant Commissioner of Bert arfard / Customs Nominee of Commissioner of Customs, General, Air Cargo, Sahar 9 at vetara aplelt sar fader Snh ssedra, ATE wat & arfAdt Shri Dhananjay Koli Industry Inspector Nominee of DC Industries, Government of Maharashtra ----- End of picture text -----

9 at vetara aplelt sar fader Snh ssedra, ATE wat & arfAdt Shri Dhananjay Koli Industry Inspector Nominee of DC Industries, Government of Maharashtra ----- End of picture text -----

aft SI Hest We faferige arfereargt Svante esas Shri. Jay Manoj Shah Specified Officer JNPA-SEZ 7 Srarcdt faa arfFrarx IITA ICC OR | wea " Smt. Smitha Nambiar _. Specified Officer , MINDSPACE-SEZ eer wot, afasr (eq Ber), at Teme wee, Shri Hanish Rathi, ADC (New SEZ), Shri Palash (est-Sst), ft radia, Bfast (= Ast), A Shankar, ADC (SEEPZ SEZ), Shri Jai deep, ADC fe, fast (Ay Ast), a Wee Raecrae, (NEW SEZ), Shri Soodershan Shindde, ADC (New (= Ast), Ht srr Ganz wat, ala3t (sez), shri Rahul Shivannagol, ADC (NEW SEZ), Shri aR. yt Feat Feat TH (s14fet) Hh. Hh. ow .3t ~ ~ Aman‘ Kumar: Sharma,~ Sharma,~ ADC: :(NEW°- SEZ) and :-Ms:- :(NEW°- SEZ) and :-Ms:- and :-Ms:- :-Ms:- = - ~~ sik Sah Sah Bars Taree & Taree & & fore safer ss safer ss ss Divyanshi Goyal (LDC) also attended for assistance and smooth functioning of the meeting. Fe ¥. ¥. 04; Rais 24.03.2026 &) araifeid 694i 694i Agenda Item No. 01: Confirmation of Minutes Minutes of oaree ager == ————.: the the GYth Méeeting held on 24.03.2026. on 24.03.2026. 24.03.2026. — awl 3s 6odt dom a aaa The Minutes of the 69th Meeting held on adasata & gfe gfe # as} 24.03.2026 were confirmed with consensus.

he the GYth Méeeting held on 24.03.2026. on 24.03.2026. 24.03.2026. — awl 3s 6odt dom a aaa The Minutes of the 69th Meeting held on adasata & gfe gfe # as} 24.03.2026 were confirmed with consensus.

st eer wot, afasr (eq Ber), at Teme wee, Shri Hanish Rathi, ADC (New SEZ), Shri Palash afast (est-Sst), ft radia, Bfast (= Ast), A Shankar, ADC (SEEPZ SEZ), Shri Jai deep, ADC Gaslt fe, fast (Ay Ast), a Wee Raecrae, (NEW SEZ), Shri Soodershan Shindde, ADC (New afaat (= Ast), Ht srr Ganz wat, ala3t (sez), shri Rahul Shivannagol, ADC (NEW SEZ), Shri co Sp). aR. yt Feat Feat TH (s14fet) Hh. Hh. ow .3t ~ ~ Aman‘ Kumar: Sharma,~ Sharma,~ ADC: :(NEW°- SEZ) and :-Ms:- :(NEW°- SEZ) and :-Ms:- and :-Ms:- :-Ms:- = - egal sik Sah Sah Bars Taree & Taree & & fore safer ss safer ss ss Divyanshi Goyal (LDC) also attended for assistance

Wis! Fe ¥. ¥. 04; Rais 24.03.2026 &) araifeid 694i 694i Agenda Item No. 01: Confirmation of Minutes Minutes of depp oaree ager == ————.: the the GYth Méeeting held on 24.03.2026. on 24.03.2026. 24.03.2026.

24.03.2026 awl 3s 6odt dom a aaa a adasata & gfe gfe # as}

o. 01: Confirmation of Minutes Minutes of depp oaree ager == ————.: the the GYth Méeeting held on 24.03.2026. on 24.03.2026. 24.03.2026.

24.03.2026 awl 3s 6odt dom a aaa a adasata & gfe gfe # as}

WislHe B02: Rt alearsrea dad wisde fees ; Ger Veaie wagers 4: aeqeltg & dexersheaSerpeva sr Agenda Item No.ee02: ProposaltOP of M/s. Onnsynex” aor differs art tg w as sag enita oe Ventures Private Limited for setting up of a new wae HEAT unit for warehousing and storage & Logistics of . Items at JNPA SEZ. . tae aimagira dad wgde fees 9 cierig M/s. Onnsynex Ventures Private Limited has wgas aa 4 wivadl wndiserpis We-SaetR 4 applied for setting up a FTWZ Unit for Warehousing PRETSH FAX 3 4 1000 a a pet H aeRETeheT Ta and storage & Logistics of Items at JNPA SEZ area ae ialiaeee mae hee ros ; garg: Vat ae & fery arden fear 81 ga eT . AS areaBe admeasuring to 1000 sq. ft. at warehousebale no. ast . 3 in NSBP FTWZ Co-developer envisaging FOB 15 &t safer 4200 ara wat & wnsitet fafa sez, value of Export Rs. 200/- in Lakh, FE Outgo of Rs. cies worl cor feeht Gar Ae Te 185 ARS GH FT 45 oo. in Lakh and NFE of Rs. 185.00/in Lakh warps weafaa 2, arer a5 one & tome ga Oa an Se at tae ee aorft Wee 31 , over a period of 5 years with employment generation of 5 employees.

85 ARS GH FT 45 oo. in Lakh and NFE of Rs. 185.00/in Lakh warps weafaa 2, arer a5 one & tome ga Oa an Se at tae ee aorft Wee 31 , over a period of 5 years with employment generation of 5 employees.

fryofa: sqAea aaa a ue ate fea fH afae 4 Decision: Approval Committee noted that the unit sate fer scr ad ot fice has not submitted the detailed HSN Code for the . fedeoTHSN ws star aét setfra letBI UUs items to be warehoused or to be stored. . After deliberation, the Committee approved fraz-faaetl ch ae, ufafa a feafafaa aed ie proposal as per attached layout subject to thet Wears Ht Hea; THM HATAoRY: & 4: ollowing conditions: SaleCARAats mega Pra we be1. warehousedTo submit itemsor stored. wise HSN Code for the items to 2. sas of Shoftendt aer arfticy wd vert 4area =«2. The unit shall adhere to and comply with all an APT OR GIT Sh aeuf, fe a aiSer} restrictions,issued from timeguidelines,to time by theand DGFTinstructionsand the , Ua Peal ar vert wea eT, GT VaysgeTgat Ministry ofCommerce & Industry, as applicable to igary a 3 SEZ units. 3. = ort ~~ 3. The unit shall exercise due diligence and ensure 301g Sf Wa REI oa WATS compliance with all conditions prescribed under the oHfeirray, 2005 vd sae sierit FayTe Fea @& =~ SEZ Act, 2005 and the rules framed thereunder. aed fafa ait sat or Wot Sure ortact 4, Committee directed Specified Officer, JNPA SEZ PRAT — BIT tosame.visit the premises and submit their report for the 4. uffa + Ae aftent, adie wears oT oRaE cot ar pet ae Sa eT F st Rave Wega oer ar Pear ears | | wist He _¥_03: Suef -erar ser forteor : RES Agenda ItemNo.

the premises and submit their report for the 4. uffa + Ae aftent, adie wears oT oRaE cot ar pet ae Sa eT F st Rave Wega oer ar Pear ears | | wist He _¥_03: Suef -erar ser forteor : RES Agenda ItemNo. 03: Pro | , arr as F art g No. : Proposal of M/s. Nhava AlgeraerdiyBar fea 1.67.145.952vapeatct Terrasea4 Alex wey Sheva Business Park Ltd. for addition of area of wae Wea 1,67,145.952 Sq Mtrs in their existing Unit Located NSBP-FTWZ JNPA without revision in projections. eatgowndisseprsFT ot[4] .dhe[fer] wees[8,][4] :[1,67,145.952] ah,, a Tutta4 Alex the unit had submitted the applicatipplication for additioniti ad 4 Petaare scatSTTaesT (atsteera) oedet fear 4 feret 2) ge die amdeaa fea Ra r projectionsOf area of 1,67,145.952into already SqexistingMtrs withoutSEZ Unit revisionlocatedin TA Si Ger st, SHS F ATA EAM ex sip sya Yat NSBP-FTWZ The proposed change in items of ay 5 asf At safe & fe sie dfea & seas 4 fasfor manufacturing and revised projection’s in LOA as agen 4 aah ar of} weare fear ~ below:-

==> picture [575 x 545] intentionally omitted <==

tems of ay 5 asf At safe & fe sie dfea & seas 4 fasfor manufacturing and revised projection’s in LOA as agen 4 aah ar of} weare fear ~ below:-

==> picture [575 x 545] intentionally omitted <==

----- Start of picture text ----- a Revis and Location: { | Existing& AdmeasuringLocation LocationProposedfor LocationProposedPost : Area addition & addition & ! Admeasuring | Admeasuring | | NSBP Co- Plot 2, NSBP Co- | Plot 2, NSBP Co- | Developer, JNPA- | Developer, JNPA- | Developer, JNPA- SEZ SEZ SEZ Admeasuring Area— 222 Area“Admeasuring— 44992.20 | - MaMa_ | taASBA82ser 8a. ——— a of Sq. [Meter] 1,67,145.952 Sq | (1,67,145.952’ + eff Meter | 4499220) —— The unit has provided that there is revision | : J]oo __. in employment projections due to proposed addition: | — Employment Projections for Next 5 Year ; Isr. No.| Particulars 15* Year| 2nd 3rd 4th 5th Year | year | Year | Year | A {Skilled and | Semi | Employees | | Skilled H | Indirect 4 12 20 Employees Total 21 Employees ----- End of picture text -----

fewla: fraz-faaet 2 a2, ufffa & Nnava Sheva : ferqstBusinessNSBP-FTWZPark Ltd.JNPA& 38& Ruawearasahaw deptatser &ufetea, . H 1,67,145.952 dat Alext a aa asa & aa wér ars ff]

Decision: After deliberation, the Committee approved the proposal ofNhava Sheva Business Park. Ltd. for addition of area of 1,67,145.952 Sq Mtrs in their existing Unit Located NSBP-FTWZ JNPA. With condition that this open space should be not reserved for public utility 7 common place fear.

. Ltd. for addition of area of 1,67,145.952 Sq Mtrs in their existing Unit Located NSBP-FTWZ JNPA. With condition that this open space should be not reserved for public utility 7 common place fear.

sah sora, Batt a fice afters ar ge fear. fe at arate at silfdes fatter Role git sa favre & ule ws geet seat a utter at ert al Further, the Committee directed the Specified que @ Ruré sa & Mad veda wt | ae fachy officer to provide the physical inspection report to ada A UIST eet a qe ures anfeata wl II the office regarding if any challenges faced by Gt wn dafeum caaee & aed squad ct ag | custom for examination of containers . This . . permission has been sanctioned due to present war like situation in gulf countries .

WisTe_¥.04:tre raion 2 ehst_fett cS ENT Agenda Item No. 04: Proposal of M/s. Aquatic ofS mfafafeat a fav ager ar al & aie at Remedies Limited for Approval W.r.t (Broad Beneslg wecfeletTeFelaESI TAT Set wrote A ply Banding)oo of list of items for Trading; activityain their existing Letter of Approval without revision in projections. aie& fay+ stageFIGerht atctex 4aitsfafsa sigaer separ4 Sfsa sisafefafeai(sis = The(BroadunitBanding)had submittedas mentionedan applicationin List offor Additionitems for SST) Sq WH AMA Wega feat eT trading activity in their existing Letter of Approval.

—

sisafefafeai(sis = The(BroadunitBanding)had submittedas mentionedan applicationin List offor Additionitems for SST) Sq WH AMA Wega feat eT trading activity in their existing Letter of Approval.

—

|—|PineApprovedItems:aee<br>sm[HS Oe/<br>Item Description<br>CPC<br>[| ssezr00 |<br>Ascorbic Acid (Vitamin C)<br>|<br>2 | 29393000 |<br>Caffeine Anhydrous<br>[ 3 | 2941030|<br>Amoxycillin Trihydrate|ee<br>|<br>.<br>°<br>|<br>.<br>.<br>||ee<br>|<br>.<br>°<br>|<br>.<br>.<br>||ee<br>|<br>.<br>°<br>|<br>.<br>.<br>||ee<br>|<br>.<br>°<br>|<br>.<br>.<br>||
|---|---|---|---|---|---|
|| 3 | “29419030<br>Enrofloxacin<br>eeos | asnso:0<br>|“Amoxicillin” Sodium &-Potassiuny <br>Clavulanate||~ Oo ee<br>es||||
||BES<br>~ Cefoperazone Sodium<br>| 12 | 29419090<br>Ceftriaxone Sodium Sterile||<br>||||.|
||Clavulanate Potassium<br>Diluted|||||
||[1s [ssosees0 |__rvpeao—_—<br>j[|<br>|<br>Iproposed Authorized operations Below: —_<br>||||,||
|||<br>|<br>Doxycycline Hyclate Bp/Ip, -M/S<br>|<br>Scott-Edil Pharma, M/S Nem<br>i<br>Laboratories, M/S Theon Pharma, | 29419090<br>M/SAkumsDrug**s**And<br>i<br>Pharmaceutical<br>AmberGlassBottle<br>70109000|5000<br>=<br>5000|||Free/Prohibited<br>/Restricted<br>Free<br>ree||<br>|<br>|<br>||

M/S Theon Pharma, | 29419090 M/SAkumsDrugsAnd i Pharmaceutical AmberGlassBottle 70109000|5000 = 5000|||Free/Prohibited /Restricted Free ree|| | | ||




```text
||||Pharma, M/S FORGO||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
||.||||29329990|5000|||Free||||
||||PHARMACEUTICAL, M/S MASCOT||||||||||
|.|||HEATH SERIS<br>P.LTD||||||||||
||||Acyclovir Ip,<br>- M/S Fde Ltd, M/S||||||||||
||||||||||||.||
||||Arihantanam<br>Lifecare<br>Pvt.Ltd., M/S}||29335990|5000_—C|||Free||||
||||Macleods Pharamaceuticals<br>Ltd||||||||||
||||Alpha Lipoic Acid, -M/S Akums||||||||||
|||7|Drugs & Pharmaceutical, M/S|.|29349990|5000|||Free||||
||||Spansules Pharma, M/S Stabicoat,||||||||||
||||[27||M/S Supreem Pharmaceuticals<br>| auminum cepsorvis <br>Amikacin Sulfate Ip, -M/S Aristo|—<br> ||rorosee | sooo ||||tee||.<br>||Cd<br>||
||||Pharma<br>Ltd, Ms/ Macleods<br>Pharmaceuticals Ltd., M/S Lifestick||29419090|9000||,|™Ri||||
||||Pharma||||||||||
||||Ampicillin Trinydra Te<br>Ip, -M/S||||||||||
|;||10|Scott Edil Pharmaceia, M/S<br>Uni||29411020|5000|||Free||||
|||<br>an||Medico, M/S Milan Laboratories<br>Amoxicillin Sodium And Potassium<br>Clavulanate, -M/S Zydus|||4||||||||
||||Helathcare Ltd, M/S Alkem||30032000|5000|||Free||||
||||Laboratories, M/S Karanataka||||||||||
||||Antibiotics<br>Ltd||||||||||
||||Amoxicillin Trihydrate Compacted,|-|||||||||
|||1|M/S<br>Milan<br>Laboratories, M/S||ayaiiase||||Free||||
||||Scottedil Phamaceia, M/S Medicef||||||||||
||||Pharma||||||||||
||||Antipyrine Usp, M/S Intracin||||||||||

drate Compacted,|-|||||||||
|||1|M/S<br>Milan<br>Laboratories, M/S||ayaiiase||||Free||||
||||Scottedil Phamaceia, M/S Medicef||||||||||
||||Pharma||||||||||
||||Antipyrine Usp, M/S Intracin||||||||||
|||13|Pharmaceuticals, -M/S Safecon||29331100|5000|||Free||||
|,<br>.||<br>||14|Lifesciences, M/S Veko Care<br>Ascorbic Acid Ip, M/S Bajaj<br>Helathcare, -M/S Rosseta Lifecare,}||29362700|5000|||Free||||<br>||
||||M/S Kwality Pharma||||||||||
||||Aspartam Powder, -M/S Swiss||||||||||
|||15||Pharma, M/S Yash Medicare, M/S|||29242990|5000|||Free||||
|||||DivineLaboratories|||,||||||||

||||Azithromycin Ip/Usp/Ep, -M/S<br>Theon Pharma, M/S Hetero Drugs,||29419090||5000||Free|||
|---|---|---|---|---|---|---|---|---|---|
|||M/S Akums Drugs|||,|||||
|||Aztreonam For Injection Usp (Bulk||||||||
|||Drug<br>}(Dry Mixure For Sterile||||||||
||||||||||||
||17||Aztreonam & Arginine)- M/S Gmh}|29419090||5000||_ Free|||
|||Laboratories, M/S United Biotech,<br>M/S Oscar Remedies|||||||<br>|||
|||18|Benzathine Benzvlpecillin With 1 %<br>|Lecithin Bp- M/S Bharat Pyrental,}|29411099||5000||Free|||
|"cary|por irik22 MzScJackson laboratories:<br>2||fective|yn|teswhitpotiseiii|||rretin: |ee|ee|
|||Betamethasone Bp/Ep/Ip/Usp-||||||!||
|oo||M/S Zydus Cadila, M/S Unison |29372200| =5000,|||5000,|||ree|||
||||||-|||||
|||Pharma|||||.|||
|____||<br>20 | ___nevafibrate<br>tp_____|29242000<br>|__sooo |roe|||||||||||
||.|Caffeine Anhydrous<br>Ip~ M/S||||||||
||||||||||||

|29372200| =5000,|||5000,|||ree|||
||||||-|||||
|||Pharma|||||.|||
|____||<br>20 | ___nevafibrate<br>tp_____|29242000<br>|__sooo |roe|||||||||||
||.|Caffeine Anhydrous<br>Ip~ M/S||||||||
||||||||||||
|i<br>|<br>H<br>|<br>|<br>|||21<br>22|Scottedil Pharma, M/S Inga<br>Laboratories, M/S Rivpra<br>Formulation<br>Calcium Pantothenate Ip- M/S<br>Flamingo Pharmaceutical, M/S ||29393000<br> 29362400||5000<br>5000||Free<br>Free||<br>||.|
||.|||||||||
|||Centurion Healthcare||||||||
||<br>|<br>|<br>i<br>i||23<br>24|Carbamazepine Bp- M/S Glumex<br>Pharmaceuticals<br>Carbidopa Ip- M/S Intas Pharma,|29339990<br>29280090||5000<br>5000||<br>,|Free<br>Free|||
|||;<br>M/S Eurokem<br>Laboratories||||||||
||25|Cefadroxil Usp (Compacted Grade)-|29419090||5000||Free||||
|||M/S Brawn<br>Laboratories||||||||
|||26|Cefalexin Monohydrate Compected|<br>Bp- M/S Sai Pyrental, M/S|—<br>29419020||5000||Free|||
|||Globela Pharma||||||||
|||Cefipirome Sulphate<br>(Sterile)<br>Ip-|||||||‘|
||27||29419019||5000||Free|||
|||.<br>M/S<br>Protec<br>Telelinks||||||||
||||.|.|||||.|
|||Cefoperazone Sodium|||||;|||
|||(Sterile Ip/Usp- M/S Karanataka|29419090||5000||Free|||
|||oo<br>Antibiotics, M/S Gepach||||||||
|||International,M/SIntasPharma||||||||

;

| ||||.|.|||||.| |||Cefoperazone Sodium|||||;||| |||(Sterile Ip/Usp- M/S Karanataka|29419090||5000||Free||| |||oo Antibiotics, M/S Gepach|||||||| |||International,M/SIntasPharma||||||||




; 

```text
||||Ceftazidime For Injection<br>(Bilk|||||||
|---|---|---|---|---|---|---|---|---|---|
|.||29 ||Sterile Ip)- M/S Pace Biotech,|| 29419019||||Free||
||||M/S Gmh<br>Laboratores|||||||
|:||30|Ceftiofur Sodium<br>Sterile<br>(Vet)-<br>M/S Intracin Pharma, M/S<br>Bovicure Pharma|29419019|,<br>5000|Free<br>pom|||||
||||Ceftizoxime Sodium (Sterile)|||||||
|||31|jJU.S.P- M/S Safecon Pharma, M/S}|29419019|5000|||Free||
||||Intracin Pharmaceuticals|-||||||
|||32|Cefuroxime Sodium Sterile Ip/Usp,<br>|- M/S Scottedil Pharamciea, M/S||29419090|5000||||Free||<br>||
||||Laborate Pharmaceutical|||||||
|||| <br>a5|Seudeema <br>Pharma, M/S Rpl tndia Ltd<br>Chorionic Gonadotrophin||e | we|<br>29414000<br>5000|||||Free||<br>i|
||||||||||||
||||Ip/Bp(Hcg) Refine Powder Bp.|p-|||||||
|;||34|M/S Gufic Bioscience, M/S<br>Sanzyme Ltd|29372100|3000|||Free|||
||||Labotories,.

otrophin||e | we|<br>29414000<br>5000|||||Free||<br>i|
||||||||||||
||||Ip/Bp(Hcg) Refine Powder Bp.|p-|||||||
|;||34|M/S Gufic Bioscience, M/S<br>Sanzyme Ltd|29372100|3000|||Free|||
||||Labotories,. M/S Cadila Pharma<br>=|ceycatoneeen|<br>ome] mm | oe<br>|<br>Pharma,<br>M/S Sunvet Healthcare<br>Clarithromycin<br>Ip Usp- M/S||||||||
|||37 ||Saphnix Lifescienes, M/S Shukra|| 29419090|5000|||Free||
||||Pharmaceutical||||||||
||||Clavulanate<br>Potassium<br>Diluted||)||||||
||||(Clavulanate Potassium||||||||
|||38|Microcrystalline- M/S Maxim<br>||29419090|5000|||Free|||
||||Pharma, M/S Bonsai Pharma,||||||||
||||M/S Unimedico||||||||
||||Clavulanate Potassium Diluted||||||||
|-||<br>|<br>||39|(Clavulanate Potassium Silicon<br>Dioxide){!:!) Ip- M/S<br>Finecure<br>Pharmaceuticals, M/S Nestor<br>Pharmaceuticals|29419090|5000|||Free<br>)||<br>||
|||40|Clindamycin Hydrochloride Ip, -<br>“M/S Sanjivanee Pharma, M/S|29419019|||_|Free|i]<br>||
||||IntasPharma<br>||||||;|||

s, M/S Nestor Pharmaceuticals|29419090|5000|||Free )|| || |||40|Clindamycin Hydrochloride Ip, - “M/S Sanjivanee Pharma, M/S|29419019|||_|Free|i] || ||||IntasPharma ||||||;|||




```text
||41||Clindamycin Phosphate Ip- M/S<br>Intas Pharma|29419040||,<br>5000|,|Free||i||
|---|---|---|---|---|---|---|---|---|---|---|---|
||||||||||||.|
||||Colistimethate Sodium Ep|29419090||5000||Free||||
||||Cyclocerine|29419090||5000||Free||||
||||||||||||||
|||Cynocobalamin (Vitamin B12) Ip||| 29362610||5000||Free||||
||||D-Calcium Pantothenate|29362990||5000||Free||||
|}|46|Dexamethasone Sodium Phosphate||29379090||5000||Free||||
||||Ip- M/S Intas Pharma|||||||||
||47|Dicyandiamide 99.7 Pct Min- M/S||29262000||5000||Free||an||
||48||Socomed Pharma, M/S Emil|29331999||5000||Free||i||
|eensGan, ey oyna<br>=<br>Pharma aeee||||eo|or|- ad we|- ams<br>eeees cee ee es|as eeee||ws {|----||
||||Echinocandin B Cycle-Peptide|||||||||
|~|{| 49<br>|||||NucleusHydrochloride<br>Salt =|29349990|5000|<br>(Ecbn.Hcl)|||||Free|;<br>|||||
||50|Enoxaparin Sodium Ip- M/S Intas<br>Pharma||29420090||||Free|||<br>||;|
|||51||Erythromycin Thiocyanate Hplc<br>Grade|29415000||5000|,|Free||||:|
||Faropenem Sodium (Non-Sterile<br>52 |Bulk)- M/S Supermax Drugs And| 29420090<br>Pharmaceuticals|||||||Free||i<br>|||
||||Fluorouracil Ip|29335990||5000||Free||||
||54|Fosfomycin Sodium Ep- M/S Bdr||29419019||5000||Free|—|||
||||Pharmaceutical|||||||||
||55|Furazolidone- M/S Haffkine Ajintha<br>Pharmaceutical<br>;||29349200||5000||Free||||
||56||Gentamicin Sulfate Ip- M/S|29419040||5000||Free||||

9419019||5000||Free|—|||
||||Pharmaceutical|||||||||
||55|Furazolidone- M/S Haffkine Ajintha<br>Pharmaceutical<br>;||29349200||5000||Free||||
||56||Gentamicin Sulfate Ip- M/S|29419040||5000||Free||||
||||;<br>Skymap Pharmaceuticals|||||||||
||57|Gliclazide Bp/Ip- M/S Lok Beta<br>;<br>Pharmaceutilcas||29420090<br>1||||Free|||.|
||||Griseofulvin Ip/Bp~ M/S Ajanta|29419090||||Free||||
||||Pharma|||||||||
||||Heparin Sodium Ip/Usp~ M/S|30019091||5000||Free||||
||||Pace Biotech|||||||||
|||60||HyaluronicAcid|39139090||5000||Free|||||

. .

|||Hydrocortisone Acetate Bp Ip- M/S|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|||ae<br>Zydus Cadila Pharma|29379090||5000|||Free|||
|||HYPROMELLOSE {Kloom)|39123929||5000||||||
|||Indomethacin Ep/Ip<br>||29339900||5000||||||
||67|L-Carnitine -L-Tartrate- M/S Zydus|29239000||5000|||Free|||
|||;<br>Cadila Pharma|||||||||
||| 68|-L-Cysteine Hydrochloride U.S.P.||. 30049099||5000.|:|||Free||||
|||Levamisole Hydrochloride {Vet ) Ip|29349990||5000|||Free|||
|||/Ep||||||||i|
|||Levodopa<br>Ip- M/S Intas Pharma|29225090||5000||||||
||71|Levofloxacin Hemihydrate Ip- M/S|29349990||5000|||Free|||
|||Cadila Pharmaceuticals||||||||||
||72|Levomisol Hydrochloride Ip Bp-<br>—<br>M/S Karnatak Antibiotics|29349990||5000|||Free||**|**<br>||
||73|Lincomycin Hydrochloride Usp/Ip-<br>;<br>M/S Carewin Pharmaceuticals|29419090||5000|||Free|||<br>i<br>i|
|||Mecobalamin- M/S<br>Intas|||||||||
||76|Pharmaceuticals, M/S Supreem|29362690||5000|||Free|||
|||Pharma||||||||||

de Usp/Ip-<br>;<br>M/S Carewin Pharmaceuticals|29419090||5000|||Free|||<br>i<br>i|
|||Mecobalamin- M/S<br>Intas|||||||||
||76|Pharmaceuticals, M/S Supreem|29362690||5000|||Free|||
|||Pharma||||||||||
||77|Menotrophin Bp/Usp<br>{Hmg)<br>?<br>ainda<br>°<br>Refine Powder Bp Usp|29371900|||||Free|||<br>|<br>||
|||Meropenam With Sodium||||||||||
||78||Carbonate Sterile Usp- M/S United]<br>Biotech, M/S Pace Biotech|29339990||.|5000|||Free|||<br>||
||<br>||Metamizole Sodium Ep<br>29331990<br> [30|<br>Methylcbaiamin Jp | 29362690 <br>PatMethylprednisolone Ip/Bp/Usp/Ep|<br>29371900|||||5000<br> __5000<br>5000||||;||<br>||
|||Metronidazole Ip/Bp- M/S|||||||||
||82|Intermed Laboratories, M/S<br>Jackosn Laboratories|29332920|||||Free|||<br>i|
|po|||||.|||||||

|||||83|Mifepristone Ip- M/S Akums Drugs<br>& Pharmacueticals, M/S Accent ||29372900|29372900||5000||,|Free||||<br>i||<br>i||<br>i|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||||||Pharmaceutical & Diagnostics|||||||||||||
||||||Misoprostol Dispersion- M/S Mepro|||||||||||||
||||||Pharmaceutical, M/S G.D|29379090||||||Free||||||
||||||Laboratories, M/S Sterile Gene<br>Life|||||||||||||
||||||Mitomycin Usp|29419090|||5000|||Free||||||
||||||Naproxen Sodium Usp- M/S|29189990|||5000|||-<br>Free||||||
||||||Flamingo Pharmaceuticals|||||||||||||
|wes|«|one||Neomycin Sulphate Ip- M/S<br>of aE leone engren<br>an ene mescals||AEE EDO||mc|penned GOS|vem|yearn owe ese|BBE|cone|ow||<br>carl|can|=|
||||||Nitrofurantoin Macro|29349990|||5000|||||||||

wes|«|one||Neomycin Sulphate Ip- M/S<br>of aE leone engren<br>an ene mescals||AEE EDO||mc|penned GOS|vem|yearn owe ese|BBE|cone|ow||<br>carl|can|=|
||||||Nitrofurantoin Macro|29349990|||5000|||||||||
|ay ~------ Norefloxacin-Ip- M/S-—kLaborate --4- <br>|<br>89<br>Pharmaceuticals, M/S Infinity<br>jeene aere,—-—-Laboratories-—---<br>—<br>|<br>Nystatin Usp- M/S Mcw<br>|<br>Healthcare||||||--- as pases<br>29335990<br>29420090|ee|SeARIRAS 4 te|<br>5000||||Free<br>— <br>Free||ESTeer|ae<br>Teer HelaIeet<br>|<br>||||
|||||92|Oxytetracycline Hydrochloride Vet|29413020|||5000|||‘Free|||ij}||-|
||||||lp/Bp/Usp/Ep||||||||||rig|||
|||||||Para Chloro Benzaldehyde 99% ||29130030|||5000|||Free||||||
|||||<br>| <br>|||Paracetamol Bp- M/S<br>Tiruvison<br>94<br>.<br>Medicine<br>95 | __ Photoiniiatort173<br> | 96 | Piracetam Ip- M/S Pace Biotech | <br>Prednisol**o**n**e** Ip2014/Ep9/Usp40| <br> | 98 |<br>Pr g sterone Bp/ip<br>| 99 |<br>Pypk 30||29242930<br>29143990 <br> 29337990 <br> **29372**1**00**<br>3<br>39059990|<br>|5000<br> |<br>__5000<br> | 5000<br>**5000**<br>5000||||Free<br>Free<br>Free<br>Free|||i<br>||||
||||||||||||||||||.|
||||||Pyridoxine Hydrochloride (Vitamin<br>B6)|29362500|||5000|||Free||||||
||||||||||||||||||||
||||||Rifampicin Ip- M/S Unicure|29419011|||5000|||Free|||||.|
||||||;<br>Remedies|||||||||||||
||||||Roxithromycin Ep- M/S Prochem|29419090|||5000|||Free||||||
||||||;<br>Pharmaceuticals|||||||||||||
|||||||||||||||||.|||
||||||$m6100d|29161290|||5000|||Free||||||
||||||Sm 6338|29161290|||5000|||Free||||||
||||||SodiumValporate|29159099||||5000|||Free||||||

Pharmaceuticals||||||||||||| |||||||||||||||||.||| ||||||$m6100d|29161290|||5000|||Free|||||| ||||||Sm 6338|29161290|||5000|||Free|||||| ||||||SodiumValporate|29159099||||5000|||Free||||||




; 

. 

fe 

: 

```text
||||Sodium Ascorbate- M/S Radicura|Sodium Ascorbate- M/S Radicura||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
||||.<br>Pharmaceuticals||29362990|5000|||Free|||
|||107|Spironolactoneip- M/S Ipca||29322090|5000|||Free|||<br>i|
||||Laboratories|||||||||
||||Sterile Mixture Of Meropenem And|||||||||
||||Sodium Carbonate- Ms Venus||29419090||||Free|||
||||Remedies|||||||||
||||Streptomycin Sulfate Non-Sterile||29412010||||Free|||
||||(Vet}Ip/Bp/Ep|||||||||
||pape|TO:|Sucralfate Ip /Usp- M/S Dr'reddy<br> | =e ew ioe<br>[Pe<br>**e**<br>**e**<br>Soy<br>Laboratories||BAGOQGO|5000|||i|7|||
|||~<br>111|| Sulbacatam Sodium |Ip/Usp- M/S||29419019|5000|||Free|||
||||;<br>Cadila<br>Pharmaceuticals|||||||||
|||113|Telmisartan Ip- M/S:Jackosn||29339900||||Free|||
||||;<br>Laboratories|||||||||
|||||||||||.||
||||{Thiamine Hydrochloride (Vitamin|BI||||||||
|||115|Hydrochloride) Ip- M/S Biocera||29362210||||Free|||
||||Pharmaceuticals|||||||||
||||Thiamine Mononitrate (Vitamin|Bl||||||||
||||Mononitrae<br>)lp~ M/S Centurion||29362210|5000|||Free|||
|||||Healthcare|||||||||
||||Tranaxamic Acid<br>Ip||29420090|5000||||||
||||N'losin TARTRATE VET<br>IP||29419090|5000|||||||
|||122|Urofollitropin Bp/Usp-Nf(Fsh)||30043990|5000|||Free|||
||||Refine Powder|||||||||
||||Ursodeoxycholic Acid<br>Ip||29181690|5000||||||

|||||
||||N'losin TARTRATE VET<br>IP||29419090|5000|||||||
|||122|Urofollitropin Bp/Usp-Nf(Fsh)||30043990|5000|||Free|||
||||Refine Powder|||||||||
||||Ursodeoxycholic Acid<br>Ip||29181690|5000||||||
|||325|Vancomycin Hydrochloride<br>( Bulk<br>Sterile )lp/Usp||29419090|5000|||Free|||
||||VinblastineSulphateIp||29372900|5000||||||

Vitamin B12 (Cynqgobalam..I-N) é eyo Prareftarh & am, wave a sez faa Decision*Alét deliberation, the” Committee 2006 * faa 19 (2) * aed, BOX Fars TS aeqait approved the proposal of M/s.Aquatic Remedies ft yet at (ais Aisa & ares B) aegait wr stza— Limited for Addition (Broad Banding) of list of items — - Fe ‘ Scum Rewil ae as mentioned above in terms of Rule 19 (2) of SEZ & sAUEME Remedies Lininst ' shi a Rule, 2006 with consensus of the Specified Officer, a we aa, aeqait &r orcad sis dS % JNPA SEZ for proposed broad banding of items. Hay A INPA SEZ & ‘fafee stare (Specified Officer) ht Weafa & aay wrt af mS al SL AS B08 ETA ia .or es i Agenda Item No. 05: Proposal of M/s. Sole Bloom ooFe eG arte esPORTS SENT" SEZ Private, Limited. (Manufacturing) located at. es eee ne JNPA-SEZ for approval w.rt’ Changeof Nameé of ~~ ~ their company. gre + srt dort & am Rad & fety ve sde4 The unit had submitted an application for Change - 7 ~~ Reger fesar-en res eo PAAR Bl ----- ------of Name: of--their- company: ~The - details -are- as -- ~~ - indicated below.

;

==> picture [464 x 404] intentionally omitted <==

for Change - 7 ~~ Reger fesar-en res eo PAAR Bl ----- ------of Name: of--their- company: ~The - details -are- as -- ~~ - indicated below.

;

==> picture [464 x 404] intentionally omitted <==

----- Start of picture text ----- a. Change in Name: From TO M/s. Sole Bloom SEZ Private M/s. Global Trade | Limited. Gateway Private Limited. | b. The details of Existing in Shareholding Pattern: Name of the} Type | No. of | Total |Amount} % of shareholder| of |shares;|Amount] of share shares (in Rs) | Share {holding Capital 1.) Mr. Siddhant| Equity 10 500 5% | | Kumar Jain 2.) Mr. Yash | Equity] 950 10 9500 | 95% | Gangwani . Ram | renal | [pee]] | tao a c. The details of Existing Existing in Board of Directors: Existing list of Board Board Board of Designation Mr. SiddhantDirectors Kumar Jain.Directors Kumar Jain. Kumar Jain. Jain. |——s—Director=|——s—Director=|=| : oe | . ----- End of picture text -----

. c. The details of Existing Existing in Board of Directors: . Existing list of Board Board Board of Designation

——s—Director=|——s—Director=|=| : oe | . ----- End of picture text -----

. c. The details of Existing Existing in Board of Directors: . Existing list of Board Board Board of Designation

Existing list of Board Board Board of Designation . . Mr. SiddhantDirectors Kumar Jain.Directors Kumar Jain. Kumar Jain. Jain. |——s—Director=|——s—Director=|=| : oe | 2.[ Wr. Yash GangwaniRam |[Director] | | a ee Se eae er rt anny sSeeraeR” We *@amuwEse sq Ua wigde fees Grgthrak) & wea oI, approved the proposal of M/s. Sole Bloom SEZ wait te ang & frear deat 109 ferig 18.10.2021 Private Limited (Manufacturing) for Change in fayo Waal& ced, Hot& ars cen Pica4 uRada @ Name of their company in terms of MoC&l Tat ataST Ter fea ax fen,STMT aed| fas se fer 4 sfeifrt toinstructioncomplianceNo. of109thedatedconditions18.10.2021mentioa n edd subjectin the said instruction. Wistye F__06: OETAoL A fer Fee Bet a“ Agenda Item No. 06: Proposal of M/s. Sole Bloom ier 8 spots ars oRacha arqstert eI SEZ Private Limited (Warehousing Activity) . , locatedName ofattheirJNPA-SEZcompany.for approval— w.r.t. Change in sas 3 set Hoel sie eee & aa cRada & fey The unit had submitted an application for Change SEA Wega feat emt six faaor Ae fey 7g 8 of Name of their company. The details are as indicated below.

==> picture [574 x 683] intentionally omitted <==

had submitted an application for Change SEA Wega feat emt six faaor Ae fey 7g 8 of Name of their company. The details are as indicated below.

==> picture [574 x 683] intentionally omitted <==

----- Start of picture text ----- d. Change in Name: , | ' | M/s. Sole Bloom SEZ Private M/s. Global Trade | Limited. Gateway Private Limited. | e. The details of Existing in Shareholding Pattern: | Name of the} Type | No. of| Total |Amount! % of shareholder| of |shares|Amount) of | share | . SP le Ashareslo> 222) qin Rs) | “Share Jnolding) 9° 220 0 . Capital | (INR) | .... | 4)Mr. Siddhant| Equity} .50.}..10 }.500 |. 5%. ; ee ee Kumar Jain | 2.| Mr. Yash | Equity] 950 10 9500 | 95% | ——— | Gangwani-—----— hated Saeninel Waiinieeoo ssaeaaiaanieateaeaaeainaaadmeaeniammamaamanammaamen | Ram | f. The detailsExisting oflist Existing of Board in Boardof of Directors:Designation || | Directors | Mr. Siddhant Kumar Jain Director | Mr. Yash Gangwani Ram pp ee emergei Seeer set Har GSR, as Cena or waitUi wigaewfetesong & (aversefer wiefete)WeT109feie& wet approvedPrivate Limitedthe (Warehousingproposal of M/s.Activity)Sole Bloomfor ChangeSEZ 18.10.2021 % Wael & ded, ofl & ar ae in Name of company, in terms of MoC&l instruction — Freee 4 oRad & fery sgaifec ae fear, ard Fide 4 sfaftac fe GF No. 109 dated 18.10.2021 and subject to set ar sraqurert fee Te | compliance of the conditions mentioned in the said instruction. ----- End of picture text -----

de 4 sfaftac fe GF No. 109 dated 18.10.2021 and subject to set ar sraqurert fee Te | compliance of the conditions mentioned in the said instruction. ----- End of picture text -----

, SI AG= SO,=;a a eea = ne Ss Agenda Item No. 07: Proposal of M/s. Sole Bloom * aa er pe a SEZ Private Limited (Trading Activity) located at JNPA-SEZ for approval w.r.t. Change of Name of their company.

"gars + aot cot sik Freep o art oRada @ fez The unit had submitted an application for Change Saar Meee fest al sikfearHt feu ae FI of Name of their company. The details are as indicated below.

==> picture [453 x 445] intentionally omitted <==

----- Start of picture text ----- g. Change in Name: i | M/s. Sole Bloom SEZ Private M/s. Global Trade | Limited. Gateway Private Limited. h. The details of Existing in Shareholding Pattern: , , | Name of the! Type | No. of} Total |Amount] % of shareholder| of |shares|Amount| of share shares {in Rs) | Share |holding| Capital | a 1.)Mr. (INR) | Siddhant}] Equity; 50 10 500 5% | _ | KumarMr. YashJain |Equity| 950 10 9500 | 95% | Gangwani . : | Ram | . | i. The details of Existing in Board of Directors: Existing list of Board of Designation Directors 2. Mr. Siddhant Kumar Jain |Director(| _[ Mr. Yash Gangwani Ram ----- End of picture text -----

xisting in Board of Directors: Existing list of Board of Designation Directors 2. Mr. Siddhant Kumar Jain |Director(| _[ Mr. Yash Gangwani Ram ----- End of picture text -----

far: rege frar-frrst o soxta, afta ¥¥ad Get Decision: After deliberation, the Committee som Sst siete fees (cfsa afdfafe) & weda GI, approved the proposal of M/s. Sole Bloom SEZ Tash VE ag & Pear HVAT 109 feAis 18.10.2021 Private Limited (Trading Activity) for Change in | &fayHaul & ded, sort& ary cen Peers FH oRadat@ ~=Name of company, in terms of MoC&l instruction Sat afer Hx fear, aert fe wen der F ofa No. 109 dated 18.10.2021 and subject to. cbr STATE Fea GATT | - compliance of the conditions mentioned in the said instruction.

WIS HG RET 08: Fert MAI geeteMTe ] eT Agenda Item No. 08: Monitoring of _ the ot fart af 2020-21 #1 2024-26 ht aa feivl performance of M/s. Simosis International for the period 2020-21 to 2024-25, fra af 2020-21 & 2024-25 Ht sale & fery aia ae Aina oe woemance Repo er ine ee (= os» Weaht RateRuré (APR) aM aRr.9eS APR ka STIR We EK1 to SEX Gy-25 HEwas BasiereceivedGAB submittedfrom Specifie by theicer, RARE Sek, SMe HTH gel FE it The report of Specified Officer, JNPA-SEZ ae, aera Br RAE A Sere FT TT ey en eee ee sas achieved positi afte 9 fret af 2024-25 @ ahr 310833.04 AT aT ee 833.04 Lakhs during FY ---) SRT -eelt-wawpg Earnings)["18][ fépar][ @1] - (Net -Foreign-: Exchange - are" ie aa or PS Baer LE, BENT haces.

ieved positi afte 9 fret af 2024-25 @ ahr 310833.04 AT aT ee 833.04 Lakhs during FY ---) SRT -eelt-wawpg Earnings)["18][ fépar][ @1] - (Net -Foreign-: Exchange - are" ie aa or PS Baer LE, BENT haces. «ws Pola: fede fere-fasel & soxic, ata + Ga fas, Decision: After deliberation, the Committee noted SO Fer ara pea ines performance of M/s. Simosis International in terms of Rule 54 SEZ Rules, 2006

FOR HEAHY TUTE SIT Sh TTT VAT BE The Meeting concluded with a vote of thanks to the chair.

Digitally signed byhyaneshwar Patil Date: 2026.05.12 (1:36:55 IST Shri. Dnyaneshwar B Patil Development Commissioner SEEPZ- SEZ

==> picture [543 x 341] intentionally omitted <==

----- Start of picture text -----

||||||||||
|---|---|---|---|---|---|---|---|---|
|Action Taken|for Approval|Committee|held|on|28-04-2026|.|
|.|Confirmation|of the|Minutes|of the|69th|
|[eeeee|NO.|[Meeting held on|24-03-2026|sd|
|Agenda|Application for setting up of|a new unit(M/s.|:|T|
|Item No.|02|Onnsynex Ventures|Private Limited.|)|LOA issued to the unit|
|Agenda|Application|for Addition ofLocation(M|/s.|;|:|
|Item No. 03|Nhhva Sheva Business Par: Ld.|)|Approval Letter issued to the unit|
||/“genda Item No.

s|Private Limited.|)|LOA issued to the unit|
|Agenda|Application|for Addition ofLocation(M|/s.|;|:|
|Item No. 03|Nhhva Sheva Business Par: Ld.|)|Approval Letter issued to the unit|
||/“genda Item No. 04|Application/s, Aquatic Remedies for Broad Limited.)—|Banding of|Items(M|[Approval Vetter issued.|to the unit;|
|Application|for Change|ofName(M/s.|Sole|
|”|Agenda Item‘No.05°||Bloom’SEZ Private|Limited|(Mantifacturing)|{Approval|Letter issued'to|the unit|~|
|)|
|Application|for Change|of|Name(M/s.|Sole|.|
|Agenda Item No.|06|Bloom SEZ Private|Limited|(Trading|Approval|Letter|issued to the unit|
|Activity)|)|.|
|Application|for Change|of|Name(M/s.|Sole|
|Agenda Item No.|07|Bloom SEZ Private Limited (Warehousing|{Approval|Letter issued|to|the|unit|
|.|Activity))|_|.|||
|Application for Monitoring|of|barecsthe|
|Agenda Item No: 08|Performance(M/s.Simosis|Intemational|)|[Monitoring Performancecons|was noted.'|

----- End of picture text -----

GOVERNMENT OF INDIA, OFFICE OF THE DEVELOPMENT COMMISSIONER, SEEPZ SPECIAL ECONOMIC ZONE, GOVT. OF INDIA, ANDHERI (EAST), MUMBAI . :

;

‘

AGENDA NOTE FOR CONSIDERATION OF APPROVAL COMMITTEE

a. Proposal:

The proposal of M/s, SRS Pharmaceuticals Private Limited for carrying out Manufacturing activities of various Pharma Items and Research & Development Services, as detailed in Annexure “A”, over an area admeasuring 8,500 Sq. Mtrs. at Plot No, 603, Sector-6, JNPT SEZ, developed by JNPT, Uran, Navi Mumbai — 400702. ;

b.. Specific Issue on which decisionofACisrequired: <0

4 wie

Rule 17 & 18 of SEZ Rule, 2006.

c. Relevant provisions of SEZ Act, 2005 & Rules, 2006/Instruction/ Notification :-

_ Application for Setting up ofNew Unit at JNPA-SEZ by M/s. SRS Pharmaceuticals Private Limited for carrying out Manufacturing activities of various Pharma Items and Research & Development Services.

d. Other Information: -

==> picture [451 x 424] intentionally omitted <==

----- Start of picture text ----- Proprictorship/ PartrershipHindividual/Pvt. Ltd. Company Status ofthe company artnership/Individual and statute under . A ase - ; which registered U2423MH2001PTC131384 with registration no. lee,Sr. Item(s) Description_ ITCCPCa Code Capacity | oaUnits Sodium Hydrogencarbonate (Sodium } : Bicarbonate / Baking: Soda) an 63000} 140000.00 Niae | Medicaments containing hormones or 2 | other products of Heading 2937, not | 30043919} 360000.00 Nos containing antibiotics — Other Product 3 Other Bpeeeioge and Oestogen 30043919 | 5280000.00 Nae to be | — — mai - manufacturing to be || Antihistaminic drugs; Antacids | rendered in Form F |i preparations; Antiulcer drugs; | 4 |Antiemetics and other Gastrointestinal] 30049034} 70000.00 Nos drugs, including Omeprazole and i | Lansoprazole | , Other medicaments for therapeutic or | 5 | prophylactic use, put up in measured. | 30049099 | 34330000.00 | Nos | | Researchdoses & Development or retail packsServices : 6 . 998113 / US and Data Processing in Medical 8510 1.00 Dollar Sciences and Pharmacy Prop saiaiaamareeie ~ [JNPT, Uran, Navi Mumbai — 400702. | eenou Admeasuring 8,500 Sq. Mtrs. at Plot No. 603, Sector-6, JNPT SEZ, developed by ----- End of picture text -----

| : | |

|. | ||

==> picture [573 x 721] intentionally omitted <==

u Admeasuring 8,500 Sq. Mtrs. at Plot No. 603, Sector-6, JNPT SEZ, developed by ----- End of picture text -----

| : | |

|. | ||

==> picture [573 x 721] intentionally omitted <==

----- Start of picture text ----- | | Name of Directors | Designation | ,, Anuradha Ganesh Naik Director | ; | DetaUS AfDirectors- TU | Suchet Shyamsunder Rastogi | Director ; | || No,Sr. [Name of the Shareholderi Typeshares of || Amount(Rs.) SharesNo. of | |%holdersof Share Details of |. | Suchet Shyamsunder Rastogi Equity | 49,49,999 | 49.49,999 98.99 | Shareholiting Pattern | 2, | Mahika Rastogi Equity | 50,000 | 50,000 1.00 | : | | 3. | Pooja Deshpand e | Equity | | 1 | 0.01 | i —————— eae BK i | [cost of Project ! Amount - BS Particulars Te | © SAREE EES oH HOE a: ee (Rs. | In Lacs) - ir " ~ ; " | . Land Cost 594.75 -——--- Project Cost —— L ; Construction Cost-(Civil, Blectrical, Mechanical. a =ee i Computer, Softwares, Licenses (100% Indigenous) 60.00 | | Office Capital Goods includes AV Equipments, PA [ ___ 182.99 | Plant and Equipment’s including material handin2(80 % 320.23 | indigenous & 20% Imported) : | : Total 1,455.32 ff Means of Finance: . Proposed Amount i; Sr.No. Particulars : ! (Rs. In Lacs) feos ps eee Shurceyyfinals | 1 From Existing Reserves and Surplus/Own 1404.32 | _ funds ~ | 2 | From Internal Accruals 51.00 z=a a | Particulars Rs.

ticulars : ! (Rs. In Lacs) feos ps eee Shurceyyfinals | 1 From Existing Reserves and Surplus/Own 1404.32 | _ funds ~ | 2 | From Internal Accruals 51.00 z=a a | Particulars Rs. In Lacs Investment | @ Plant & Machinery | Detuils | (i) Indigenous | 759.92 (ii) Import CIF Value 100.64 Total (i) + Gi) | 860.56 | SSS (Rs. In Lacs) | ns Ieee importJin& indigenous | Import | Indigenous requirement of | @; |anilCapitalGoodsBe|| 100.64 | 759.92 || materials: and other (b)00] |DE eeInput Services [a150.00 _[2700.00 yl inputs i Raw Material, Components, , H| | &) Packing material fuel ete, for5 year ae TESTS ee | LeesSS| Total | 663.14 | 1129742 | ----- End of picture text -----

==> picture [472 x 671] intentionally omitted <==

----- Start of picture text ----- Employment Projections for Next 5 Year Sr.No.| Particulars /18t year} 2"¢ | 3° year | 4t Year | 5 Year ° , Year ‘ A | Skilled and Semi- 9 11 30 50 90 ) Total Skilled i employment Employees | | | B Indirect 50 35 35 35 35 Employees | | Total Employees} 59 46 | 65 85 125 i ~ - = = —_ j (Rs. in Lacs) Details Exports in first five | Outgo for the first ange DATOMES aa Sue for the first five years (1)—- (2) Foreign Exchange 18t Year 500,00 119.39 | 380.61 | Balialance Sheet 1500.00 5625 | 1443.75 3° Year 3500.00 131.25 | 3368.75 | | 4h5th Year | 4055 00.00 206150 . 2500 38505293 .

(1)—- (2) Foreign Exchange 18t Year 500,00 119.39 | 380.61 | Balialance Sheet 1500.00 5625 | 1443.75 3° Year 3500.00 131.25 | 3368.75 | | 4h5th Year | 4055 00.00 206150 . 2500 38505293 . 0075 | - | Total 15000.00 | 663.14 14336.86 | ‘ | eatahte ae 15957.45 705.47 15251.98 thousands) The applicant has mentioned that, for marketing of products from the proposed SEZ Unit, they will establish a separate dedicated marketing department \Marketin ifor reaching out to prospective customers. They regularly participate in national and stiitleg a. back plan international exhibitions and trade fairs for enhancing brand visibility, generating ney P business leads, and expanding their global customer base. Further, they will focus on strengthening relationships with existing clients and exploring new export markets to ensure sustainable business growth from the proposed SEZ Unit. M/s. SRS Pharmaceuticals Private Limited (SPPL), incorporated in March 2001, is an innovation-driven healthcare company engaged in pharmaceutical manufacturing and Research & Development (R&D). With origins dating back to 1995, the company offers a diverse portfolio including antibacterial, anti-retroviral (Anti-AIDS), herbal, and patient-centric healthcare solutions. _ |SPPL commissioned a state-of-the-art oral solid dosage manufacturing facility in Palghar District in November 2023 and established a DSIR-approved R&D Centre EET . F at Rabale, Navi Mumbai in March 2023.

ssioned a state-of-the-art oral solid dosage manufacturing facility in Palghar District in November 2023 and established a DSIR-approved R&D Centre EET . F at Rabale, Navi Mumbai in March 2023. The R&D Centre specializes in TA PERT Sas formulation development, analytical development, API research, custom synthesis, stability studies, impurity profiling, and regulatory support for international i markets such as the UK and the USA. , The company focuses on innovation-driven, affordable, and accessible healthcare solutions, particularly for emerging and underserved markets. SPPL has also: : developed patient-centric innovations such as an Al-enabled stethoscope, chewable antibiotic formulations, and tablet-based oral suspensions to improve patient compliance and accessibility. i ----- End of picture text -----

—_

It is observed thatthe Unit was granted LOA No. SEEPZ/NEWSEZ/JNPT- [_—t—“— SEZ/SRSPPL/34/2022-23/21040 dated 09.12.2022 for carrying out trading activity over an area of 10,200 sq. mtrs. valid up to 08.12.2023. Subsequently, M/s. SRS Pharmaceuticals applied for deletion of 8,500 sq. : mtrs. area from the approved LoA for proposed manufacturing activity and to . use balance 1700 Sq mir for trading activity. The same was approved by approval committee and informed to unit vide letter dated 07.04.2025. Observation The proposal has now been submitted by the unit for setting up a new Manufacturing unit over the said deleted/diverted area of 8,500 Sq. Mtrs. at the same location. Further, LoA No.

Observation The proposal has now been submitted by the unit for setting up a new Manufacturing unit over the said deleted/diverted area of 8,500 Sq. Mtrs. at the same location. Further, LoA No. SEEPZ/NEWSEZ/JNPT-SEZ/SRSPPL/34/2022-23/21040 of the unit for trading activity has expired on 08.12.2026.

e. Recommendation:

~~ Proposal of M/s. SRSPharmaceuticals Private Limited for setting up of unit for Manufacturing activities of various Pharma ~ ~~ Items and Research & Development Services, over an area admeasuring 8,500 Sq. Mtrs. at Plot No. 603, Sector-6, JNPT SEZ, developed by JNPT, Uran, Navi Mumbai — 400702. is placed before the Approval Committee for consideration in termsof Rule 17 & 18 ofSEZ Rules, Z006.° FE

RRR RII RR II RIK EER RERER EEE KEE REE RRR

GOVERNMENT OF INDIA, _ OFFICE OF THE DEVELOPMENT COMMISSIONER, SEEPZ SPECIAL ECONOMIC ZONE, GOVT. OF INDIA, ANDHERI (EAST), MUMBAI KEKEHK

AGENDA NOTE FOR CONSIDERATION OF APPROVAL COMMITTEE

a. Proposal:

Application received from M/s. SRV Global Freight Pvt. Ltd. for addition of area admeasuring 4,370.05 Sq. ft. to the already existing SEZ Unit located at NSBP-FTWZ, JNPA, Uran, Navi Mumbai without revision in projections .

b. Specific Issue on which decision of AC is required: -

Approval of the addition ofarea admeasuring 4,370.05 Sq. ff. to the existing SEZ Unit located at NSBP-FTWZ, JNPA without revision in projections. .

c. Relevant provisions of SEZ Act, 2005 & Rules, 2006/Instruction/ Notification :-

Rule 19(2) of the SEZ Rules, 2006 provides as under:

“Provided that the Approval Committee may also approve proposals for broad banding, diversification, enhancement of capacity of production, change in item of manufacture or services activity if it meets the requirement of Rule 18.” ~

d. Other Information: -

)

==> picture [507 x 243] intentionally omitted <==

----- Start of picture text ----- ; Name of the Unit M/s. SRV Global Freight Pyt. Ltd Located at NSBP-FTWZ in JNPA SEZ, Uran, Navi Mumbai — 400702 [sisting Area ———*d 3 10,000 84. f | LOA No. & Date SEEPZ/NEWSEZ/JNPA-SEZ/SGF/100/2025-26/04871 Authorized Operations / Services Service Oriented Activity Validity of LOA Up to 07.05.2027 _ Proposed Additional Area . Uran, Navi Mumbai — 400702 admeasuring 4,370.05 Sq. Whether copy of Agreement / LOI Yes submitted _ Whether there is revision in projection The Office of the Specified Officer, JNPA SEZ has verified the Verification report from the Specified. proposed|qemarcatedareawithinand theconfirmedwarehousethatpremisesthe sameby hasuse beenof plyboards.properly officer Photographs of the site verification have also been submitted by the Authorized Officer. ----- End of picture text -----

A. Total Area after Addition

The details of existing and proposed areas are as under:

==> picture [453 x 15] intentionally omitted <==

----- Start of picture text ----- Existing Location & Area Proposed Additional Area Total Area after Addition ----- End of picture text -----

|ExistingLocation&Area|ProposedAdditionalArea|||‘TotalAreaafterAddition|_|||
|---|---|---|---|---|---|
|Warehouse no.03, PlotNo.406/FTWZ,||Warehouseno.03, PlotNo. 406/FTWZ,||<br>Sector-4, inM/s.NSBP, Co-developer|} Sector-4, inM/s.NSBP, Co-developer||||Warehouseno.03, PlotNo.406/FTWZ,<br>||Sector-4, inM/s.NSBP, Co-developer at|||-|
|atM/s.INPA, Village Sawarkhar,<br>Taluka-Uran, District-Raigad,Navi|atM/s.JNPA,Village Sawarkhar,<br>Taluka-Uran, District-Raigad, Navi||M/s.JNPA,Village Sawarkhar, Taluka-<br>Uran, District-Raigad,NaviMumbai-||:|
|Mumbai-400707|Mumbai-400707||400707|||
|||||Admeasuring Area—|||
|Admeasuring Area— 10,000. Sq. ft|Admeasuring Area 4370.05 Sq ft|||||
||||14,370.05(4,370.05+16,000)|||

The applicant has further submitted that employment projections have been revised in accordance with the expanded operations.

		operations.
..	...B.	Employment Projections for Next FiveYears)<br>2. 000		Be
_....	..	[Particulars<br>[ist Year]2nd<br>Year]<br> [Skilled /,Semi-Skilled Employees],1._	SthYear<br>ee<br>a	Oe

C. No Revision in Approved Projections

The unit has submitted that there is no revision in the approved projections relating to exports, investment, Net Foreign Exchange (NFE) and employment.

Further, the unit has undertaken to comply with all applicable restrictions, guidelines and directives issued from time to time by the Directorate General of Foreign Trade (DGFT) and Ministry of Commerce & Industry and to ensure compliance with the provisions of the SEZ Act, 2005 and Rules framed thereunder.

The unit has also informed that, based on its business requirements, they have revised space admeasuring approximately 14,370.05 Sq. Ft. which has been allotted by the NSBP Co-Developer and copy of the allotment letter has been submitted. The unit has stated that the allotted space is sufficient for commencement of operations. Further, in case of any future requirement of additional space, the unit shall approach the competent authority separately for necessary approval, as applicable.

ce. Recommendation:

The proposal of the unit for addition of area admeasuring 4,370.05 Sq. ft. to the existing unit located at NSBPFTWZ, JNPA without revision in projections is placed before the Approval Committee for consideration.

FAKE AKI KREUK RRR RRR KEKE REE RR REEERERKR IKE

Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.

Analysis

No analysis generated for this document yet (analysis runs over brief docs + on-demand). Run build_analysis.py --ids 27819 --apply.